155 related articles for article (PubMed ID: 8577323)
1. Characterization of a plasminogen activator produced by Acanthamoeba castellanii.
Mitra MM; Alizadeh H; Gerard RD; Niederkorn JY
Mol Biochem Parasitol; 1995 Jul; 73(1-2):157-64. PubMed ID: 8577323
[TBL] [Abstract][Full Text] [Related]
2. Characterization and pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitis.
van Klink F; Alizadeh H; Stewart GL; Pidherney MS; Silvany RE; He Y; McCulley JP; Niederkorn JY
Curr Eye Res; 1992 Dec; 11(12):1207-20. PubMed ID: 1490339
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of an extracellular serine proteinase from Acanthamoeba castellanii.
Cho JH; Na BK; Kim TS; Song CY
IUBMB Life; 2000 Sep; 50(3):209-14. PubMed ID: 11142349
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of a 33 kDa serine protease from Acanthamoeba lugdunensis KA/E2 isolated from a Korean keratitis patient.
Kim HK; Ha YR; Yu HS; Kong HH; Chung DI
Korean J Parasitol; 2003 Dec; 41(4):189-96. PubMed ID: 14699259
[TBL] [Abstract][Full Text] [Related]
5. Characterization and pathogenetic role of proteinase from Acanthamoeba castellanii.
Na BK; Kim JC; Song CY
Microb Pathog; 2001 Jan; 30(1):39-48. PubMed ID: 11162184
[TBL] [Abstract][Full Text] [Related]
6. Comparison of specific activity and cytopathic effects of purified 33 kDa serine proteinase from Acanthamoeba strains with different degree of virulence.
Kim WT; Kong HH; Ha YR; Hong YC; Jeong HJ; Yu HS; Chung DI
Korean J Parasitol; 2006 Dec; 44(4):321-30. PubMed ID: 17170574
[TBL] [Abstract][Full Text] [Related]
7. Protease activities of Acanthamoeba polyphaga and Acanthamoeba castellanii.
Serrano-Luna Jde J; Cervantes-Sandoval I; Calderón J; Navarro-García F; Tsutsumi V; Shibayama M
Can J Microbiol; 2006 Jan; 52(1):16-23. PubMed ID: 16541155
[TBL] [Abstract][Full Text] [Related]
8. Effect of immunization with the mannose-induced Acanthamoeba protein and Acanthamoeba plasminogen activator in mitigating Acanthamoeba keratitis.
Alizadeh H; Neelam S; Niederkorn JY
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5597-604. PubMed ID: 18055809
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
10. Characterization of novel extracellular proteases produced by Acanthamoeba castellanii after contact with human corneal epithelial cells and their relevance to pathogenesis.
Loufouma-Mbouaka A; Martín-Pérez T; Köhsler M; Danisman Z; Schwarz M; Mazumdar R; Samba-Louaka A; Walochnik J
Parasit Vectors; 2024 May; 17(1):242. PubMed ID: 38812022
[TBL] [Abstract][Full Text] [Related]
11. Purification and partial characterization of plasminogen activator from human uterine tissue.
Rijken DC; Wijngaards G; Zaal-de Jong M; Welbergen J
Biochim Biophys Acta; 1979 Sep; 580(1):140-53. PubMed ID: 121055
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition of protease-activated receptors 1, 2 and 4 demonstrates that these receptors are not involved in an Acanthamoeba castellanii keratitis isolate-mediated disruption of the human brain microvascular endothelial cells.
Iqbal J; Naeem K; Siddiqui R; Khan NA
Exp Parasitol; 2014 Nov; 145 Suppl():S78-83. PubMed ID: 24703976
[TBL] [Abstract][Full Text] [Related]
13. Identification and properties of proteases from an Acanthamoeba isolate capable of producing granulomatous encephalitis.
Sissons J; Alsam S; Goldsworthy G; Lightfoot M; Jarroll EL; Khan NA
BMC Microbiol; 2006 May; 6():42. PubMed ID: 16672059
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass.
Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Skriver L; Danø K
FEBS Lett; 1986 Feb; 196(2):269-73. PubMed ID: 3081367
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.
Sueishi K; Nanno S; Okamura T; Inoue S; Tanaka K
Biochim Biophys Acta; 1982 Aug; 717(2):327-36. PubMed ID: 7052141
[TBL] [Abstract][Full Text] [Related]
16. Amiloride selectively inhibits the urokinase-type plasminogen activator.
Vassalli JD; Belin D
FEBS Lett; 1987 Apr; 214(1):187-91. PubMed ID: 3106085
[TBL] [Abstract][Full Text] [Related]
17. Effect of steroids on Acanthamoeba cysts and trophozoites.
McClellan K; Howard K; Niederkorn JY; Alizadeh H
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2885-93. PubMed ID: 11687533
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis of Acanthamoeba keratitis.
Niederkorn JY; Alizadeh H; Leher H; McCulley JP
Microbes Infect; 1999 May; 1(6):437-43. PubMed ID: 10602676
[TBL] [Abstract][Full Text] [Related]
19. Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.
Husain SS; Lipinski B; Greuwich V
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4265-9. PubMed ID: 6270665
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
Sudol M; Reich E
Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
